1. Home
  2. PCYO vs ACB Comparison

PCYO vs ACB Comparison

Compare PCYO & ACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pure Cycle Corporation

PCYO

Pure Cycle Corporation

N/A

Current Price

$10.61

Market Cap

264.1M

Sector

Utilities

ML Signal

N/A

Logo Aurora Cannabis Inc.

ACB

Aurora Cannabis Inc.

HOLD

Current Price

$4.07

Market Cap

232.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PCYO
ACB
Founded
1976
2013
Country
United States
Canada
Employees
N/A
N/A
Industry
Water Supply
Pharmaceuticals and Biotechnology
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
264.1M
232.3M
IPO Year
1995
2016

Fundamental Metrics

Financial Performance
Metric
PCYO
ACB
Price
$10.61
$4.07
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
66.2K
★ 1.0M
Earning Date
11-11-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 12.50
N/A
EPS
★ 0.36
N/A
Revenue
★ $1,227,787.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$9.38
P/E Ratio
$29.03
★ N/A
Revenue Growth
★ 171.54
N/A
52 Week Low
$9.71
$2.56
52 Week High
$12.44
$6.36

Technical Indicators

Market Signals
Indicator
PCYO
ACB
Relative Strength Index (RSI) 41.63 48.85
Support Level $10.53 $3.75
Resistance Level $10.72 $4.20
Average True Range (ATR) 0.23 0.16
MACD -0.04 -0.03
Stochastic Oscillator 23.60 25.17

Price Performance

Historical Comparison
PCYO
ACB

About PCYO Pure Cycle Corporation

Pure Cycle Corp is a diversified land and water resource development company. The company designs, constructs, manages, operates, and maintains water and wastewater systems. The firm operates in three business segments namely Water and wastewater resource development, Land development, and the Single-Family Rental Segment. It generates maximum revenue from the Land development segment. The land resource development segment includes all the activities necessary to develop and sell finished lots.

About ACB Aurora Cannabis Inc.

Aurora Cannabis Inc is focused on the production, distribution, and sale of cannabis products in Canada and internationally. The Company conducts the production, distribution, and sale of medical cannabis products and, on a very limited basis, consumer cannabis products in Canada pursuant to the Cannabis Act; the production and distribution of wholesale medical cannabis in the European Union pursuant to the German Medicinal Products Act and German Narcotic Drugs Act; and the distribution of wholesale medical cannabis in various international markets, including Australia and New Zealand. Its segments are Canadian Cannabis CGU, European Cannabis CGU, Australia Cannabis CGU, and New Zealand Cannabis CGU, with Canada generating majority revenue.

Share on Social Networks: